1. Home
  2. VERO vs ACON Comparison

VERO vs ACON Comparison

Compare VERO & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Venus Concept Inc.

VERO

Venus Concept Inc.

HOLD

Current Price

$1.82

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Logo Aclarion Inc.

ACON

Aclarion Inc.

HOLD

Current Price

$6.44

Market Cap

4.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERO
ACON
Founded
N/A
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.4M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
VERO
ACON
Price
$1.82
$6.44
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$23.00
AVG Volume (30 Days)
36.1K
61.7K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,876,000.00
$67,483.00
Revenue This Year
N/A
$145.39
Revenue Next Year
$10.00
$145.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
36.91
52 Week Low
$1.65
$5.55
52 Week High
$14.50
$3,499.49

Technical Indicators

Market Signals
Indicator
VERO
ACON
Relative Strength Index (RSI) 46.16 48.03
Support Level $1.84 $5.71
Resistance Level $1.99 $6.89
Average True Range (ATR) 0.12 0.61
MACD 0.01 0.06
Stochastic Oscillator 44.78 35.04

Price Performance

Historical Comparison
VERO
ACON

About VERO Venus Concept Inc.

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Share on Social Networks: